The Clinical Significance of Achieving Different Levels of Cytogenetic Response in Patients with Chronic Phase Chronic Myeloid Leukemia After Failure to Frontline Therapy: Is Complete Cytogenetic Response the Only Desirable Endpoint?

অনুরূপ উপাদানগুলি

• Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy
  অনুযায়ী: Quintás-Cardama, Alfonso, অন্যান্য
  প্রকাশিত: (2011)
• Outcome After Failure of Second Generation Tyrosine Kinase Inhibitors Treatment As First-line Therapy for Patients With Chronic Myeloid Leukemia
  অনুযায়ী: Eghtedar, Alireza, অন্যান্য
  প্রকাশিত: (2013)
• Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 months
  অনুযায়ী: Nazha, Aziz, অন্যান্য
  প্রকাশিত: (2013)
• Similar outcome of patients with chronic myeloid leukemia treated with imatinib on or off clinical trials
  অনুযায়ী: Yilmaz, Musa, অন্যান্য
  প্রকাশিত: (2013)
• Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase
  অনুযায়ী: Fava, Carmen, অন্যান্য
  প্রকাশিত: (2009)